CYP4X1 and breast carcinoma: The endocannabinoid system is involved in various physiological processes, including inflammation, immunomodulation, and suppression of different cancers, including breast cancer; thus, CYP4X1 may play a role in the response to anticancer chemotherapy via physiological processes.